Chapter 5. Results

Table of Contents
5.1. Atopy and self-reported lifetime depression
5.2. Atopy and the severity of current depression verified by HSCL-depression subscale
5.3. Hospital-treated atopic disorders and depression
5.4. Atopy of the first degree relatives and depression of the proband

5.1. Atopy and self-reported lifetime depression

While assessing whether depression, in general, is associated with atopy, each cohort member was asked if he/she had ever been treated or diagnosed by a doctor for depression. The likelihood of depression among skin prick test positive cohort members when compared with skin-test negative ones is presented in Table 2 (II: Table 1). The result showed that 6.9% of all females with positive prick tests had been suffering from depression sometime during their lifetime, while the corresponding percentage for females with negative prick test was 4.3%. When in addition to a positive skin test response, also self-reported allergic symptoms were taken into account in defining the presence of atopy, the probability of depression in females increased from 1.8 (95% CI 1.2–2.6) to 2.7-fold (95% CI 1.6–4.6). Among males, there were no statistically significant differences in the proportions of depression (3.0% and 2.9%) in atopic and non-atopic males, respectively (Table 2; II: Table 1).

Table 2. Associations between prick tested atopies and self-administered information of doctor-diagnosed lifetime depression in the Northern Finland 1966 Birth Cohort. (II: Table 1).

Gender and atopynDepressed n (%)Unadjusted OR (95% CI)Adjusted OR (95% CI)
Men
Prick test positive90427 (3.0)1.0 (0.6–1.6)0.9* (0.5–1.6)
Prick test negative181753 (2.9)ReferenceReference
Women
Prick test positive75052 (6.9)1.6 (1.1–2.3)1.8** (1.2–2.6)
Prick test negative195785 (4.3)ReferenceReference
*Adjusting variables were father’s social class, mother’s parity, and place of residence in 1966, and cohort member’s hospital-diagnosed psychiatric disease. **Adjusting variables were father’s social class, mother’s parity, and place of residence in 1966, and cohort member’s hospital-diagnosed psychiatric disease, use of oral contraceptives, and at least one pregnancy before the age of 32.